cefuroxime axetil tablet, film coated
medvantx, inc. - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil tablets and other antibacterial drugs, cefuroxime axetil tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. note: cefuroxime axetil tablets and cefuroxime axetil for oral suspension are not bioequivalent and are not substitutable on a milligram-per-milligram basis (see clinical pharmacology) cefuroxime axetil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: 1. pharyngitis/tonsillitis caused by streptococcus pyogenes. note: the usual dr
cefuroxime venus pharma 750mg powder for solution for injection/infusion
venus pharma gmbh (0000008606) am bahnhof 1-3, werne, 59368 - cefuroxime sodium - powder for solution for injection/infusion - 750mg - cefuroxime sodium (0056238632) 789mg
cefuroxime venus pharma 1500mg powder for solution for injection/infusion
venus pharma gmbh (0000008606) am bahnhof 1-3, werne, 59368 - cefuroxime sodium - powder for solution for injection/infusion - 1500mg - cefuroxime sodium (0056238632) 1578mg
cefuroxime multichem
multichem nz limited - cefuroxime sodium 1.6 g equivalent to cefuroxime 1.5 g; - powder for injection - 1.5 g - active: cefuroxime sodium 1.6 g equivalent to cefuroxime 1.5 g - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available (see section 5.1). indications include - respiratory tract infections for example, acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. - ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. - urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. - soft-tissue infections for example, cellulitis, erysipelas and wound infections. - bone and joint infections for example, osteomyelitis and septi
cefuroxime multichem
multichem nz limited - cefuroxime sodium 802mg equivalent to cefuroxime 750 mg; - powder for injection - 750 mg - active: cefuroxime sodium 802mg equivalent to cefuroxime 750 mg - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available (see section 5.1). indications include - respiratory tract infections for example, acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. - ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. - urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. - soft-tissue infections for example, cellulitis, erysipelas and wound infections. - bone and joint infections for example, osteomyelitis and septi
cefuroxime-aft
aft pharmaceuticals ltd - cefuroxime sodium 1578mg equivalent to 1500 mg cefuroxime; - powder for injection - 1.5 g - active: cefuroxime sodium 1578mg equivalent to 1500 mg cefuroxime - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.
cefuroxime-aft
aft pharmaceuticals ltd - cefuroxime sodium 263mg equivalent to 250 mg cefuroxime; - powder for injection - 250 mg - active: cefuroxime sodium 263mg equivalent to 250 mg cefuroxime - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.
cefuroxime-aft
aft pharmaceuticals ltd - cefuroxime sodium 789mg equivalent to 750 mg cefuroxime; - powder for injection - 750 mg - active: cefuroxime sodium 789mg equivalent to 750 mg cefuroxime - cefuroxime-aft is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. indications include: · respiratory tract infections e.g. acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections.
cefuroxime axetil actavis 250mg film coated tablets
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - cefuroxime - film-coated tablet - cefuroxime 250 mg - antibacterials for systemic use
cefuroxime axetil actavis 500mg film coated tablets
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - cefuroxime - film-coated tablet - cefuroxime 500 mg - antibacterials for systemic use